Venture capital Arm of
126 Investments in 78 Companies
New Brunswick, New Jersey
Pharmaceutical, Consumer, Medical Device, Health Care, Biotechnology
Johnson & Johnson Development Corporation, a venture capital subsidiary, finances technology companies focused on patient health.

Investor Details

Corporate Venture Capital that does Seed, Early Stage Venture, Later Stage Venture, and Private Equity Investments
Biotechnology, Health Care, Health and Wellness
Canada Europe, Israel, United States

Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC is comprised of experts and leaders in the health care and technology venture communities who identify early market indicators, health care trends, and strategic investment opportunities. Unlike traditional venture capital firms, JJDC determines the success of an investment’s performance not only in financial returns, but also in the viability of providing strategic growth options for Johnson & Johnson.

JJDC plays an integral role in the identification of new business opportunities outside of Johnson & Johnson’s traditional portfolio and market presence. JJDC identifies new market opportunities and develops new businesses in emergent health care sectors while also creating support venture investments in alignment with the strategic objectives of Johnson & Johnson operating companies.

DateInvested InRoundPartner(s)
Aug, 2016$93M / Series G (Lead)
Feb, 2016$18M / Series A
Mar, 2015$40M / Series C
Nov, 2014$20M / Series B (Lead)
Sep, 2014£4M / Series A
Sep, 2014€64.5M / Series F
Jun, 2014$23.5M / Series A
Jun, 2014$55.7M / Series C
May, 2014$12.9M / Series A (Lead)
May, 2014$40M / Series E
Apr, 2014£16.9M / Series B
Feb, 2014$49M / Series B
Jan, 2014$20M / Series D
Jan, 2014£4.5M / Venture
Nov, 2013£17M / Series A
Nov, 2013€30M / Series E
Oct, 2013€31M / Series B (Lead)
Jul, 2013$55M / Series E
Jul, 2013$10.6M / Series C
Jul, 2013$29.6M / Series F (Lead)
Jul, 2013$18M / Venture (Lead)
Jun, 2013undisclosed amount / Seed
Jun, 2013$14M / Series B (Lead)
Apr, 2013$15M / Series E
Apr, 2013$18M / Series C (Lead)
Apr, 2013$5.07M / Venture
Mar, 2013$48M / Series C
Feb, 2013$30.73M / Private Equity
Dec, 2012€34.5M / Series D
Oct, 2012$30M / Series C
Sep, 2012$13.41M / Venture
Jun, 2012$40.4M / Series C
Jun, 2012$23M / Series B
May, 2012$35M / Series D
Apr, 2012$284k / Venture
Feb, 2012$43M / Venture
Jan, 2012$2.76M / Venture
Jan, 2012$12.5M / Series C
Jan, 2012€3.7M / Series C
Nov, 2011€71M / Series C

Current Team (10)


Offices/Locations (5)

  • Office

    Cambridge, Massachusetts

    United States

  • HQ

    410 George Street

    New Brunswick, New Jersey 08901

    United States

  • Office

    London, England

    United Kingdom

  • Office

    Beijing, Beijing


  • Office

    Menlo Park, California

    United States

Add Board Members and Advisors

Add Funds

Add Competitors

Add Memberships

Add Images

Add Videos